Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score as a predictive value of Incidental prostate cancer for patients going for Transurethral resection of the prostate (TURP): A Single Center Study

Abstract

AbstractAimsProstate cancer is a significant health concern worldwide, and early detection is crucial for effective treatment. This study aimed to investigate the role of the Hemoglobin-Albumin-Lymphocyte-Platelet (HALP) score in detecting prostate cancer in patients undergoing Transurethral Resection of the Prostate (TURP). Additionally, comprehensive analysis was performed to explore clinical parameters associated with incidentally diagnosed prostate cancer post-TURP.MethodsA total of 131 patients with symptomatic bladder outlet obstruction who underwent TURP were included in the study. The patients were divided into two groups: those with benign prostatic hyperplasia (BPH) and those with invasive prostatic carcinoma. The IPC group consisted of patients with both low-grade and high-grade IPC determined by Gleason score. Demographic data, including age, race, medical history, body mass index, smoking and alcohol status, and family history of prostate cancer, were evaluated. Postoperative measurement of specimen weight and prostate-specific antigen (PSA) levels were also analyzed.ResultResults revealed that approximately 50% of patients had BPH, while the remaining 50% had IPC. Patients with IPC, particularly high-grade IPC, had significantly higher PSA levels and lower resected specimen weight compared to those with BPH. The HALP score, which incorporates hemoglobin, albumin, lymphocyte, and platelet levels, showed promise as a discriminatory tool for distinguishing between BPH and IPC, as well as between high-grade IPC and BPH/low-grade IPC. Logistic regression analysis identified increased PSA levels, decreased HALP score, and smaller specimen weight as independent predictive factors for IPC after TURP. Notably, HALP score was the only significant independent predictive factor associated with high-grade IPC.ConclusionThese findings contribute to the understanding of risk factors and diagnostic tools for incidentally detected prostate cancer in patients with bladder outlet obstruction undergoing TURP. The HALP score, along with PSA levels and specimen weight, can aid in the early detection and management of prostate cancer. Further research is warranted to validate these findings and explore the clinical utility of the HALP score in predicting prostate cancer outcomes.